Piramal Alternatives has invested Rs 215 crore in Kolors Healthcare as India’s wellness market sees rising demand for preventive and personalized healthcare. The investment will support Kolors’ expansion, infrastructure upgrades...
Cancer care gets a new boost in Japan as Biocon Biologics secures marketing approval for its pegfilgrastim biosimilar. The approval expands Biocon’s oncology portfolio and strengthens its presence in Japan’s biosimilar market
Dr Reddy’s Laboratories has secured a key approval for its arthritis treatment portfolio in India. The company received marketing approval for its abatacept biosimilar from the Central Drugs Standard Control Organisation (CDSCO).
H1N1 cases have crossed 2,300 in Delhi, prompting hospitals to strengthen testing and preparedness. The capital has recorded 2,308 H1N1 cases so far in 2026. Total Influenza A and B cases have crossed around 3,000.
The US weight-loss drug market faces a new affordability challenge as employers reconsider coverage for GLP-1 medicines amid rising healthcare costs
Air pollution is emerging as a significant contributor to the global cancer burden. As the latest research places fine particulate matter at the center of the concern
Palm Bioactives are gaining attention in NCD research. Scientists are exploring whether naturally occurring palm compounds can help address non-communicable diseases
H1N1 Alert measures are being stepped up across Haryana as flu cases rise sharply in neighboring Delhi. The state has ordered wider influenza testing and stronger hospital preparedness. The H1N1 Alert comes as Delhi has reported 1,777 H1N1 cases...
The Congo ebola outbreak has recorded one of its deadliest weeks yet, with 317 deaths reported in seven days. The sharp rise has raised fresh concerns over the spread of the virus in eastern Congo. The latest figures bring the reported outbreak...
Recent developments from Johnson & Johnson, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Pulnovo Medical and Bayer highlight how pharmaceutical innovation, generic manufacturing and advanced medical technology strengthen critical care